Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 6,392 | 2,271 | 0 | 0 | 14,068 |
| Gross Profit | 6,392 | 2,271 | N/A | N/A | 14,068 |
| Operating Expenses | 128,247 | 94,181 | 84,534 | 58,998 | 98,099 |
| Operating Income | -121,855 | -91,910 | -84,534 | -58,998 | -84,031 |
| Interest Expense | 0 | 0 | 0 | 0 | 764 |
| Other Income | 5,232 | 8,470 | 3,389 | 976 | 124 |
| Pre-tax Income | -116,623 | -83,440 | -81,145 | -58,022 | -84,671 |
| Income Tax | 637 | 141 | 27 | 10 | 15 |
| Net Income Continuous | -117,260 | -83,581 | -81,172 | -58,032 | -84,686 |
| Net Income | $-117,260 | $-83,581 | $-81,172 | $-58,032 | $-84,686 |
| EPS Basic Total Ops | -12.48 | -9.37 | -53.08 | -227.42 | -123.50 |
| EPS Basic Continuous Ops | -12.48 | -9.37 | -53.09 | -227.58 | -123.27 |
| EPS Diluted Total Ops | -12.48 | -9.37 | -53.08 | -227.42 | -123.50 |
| EPS Diluted Continuous Ops | -12.48 | -9.37 | -53.09 | -227.58 | -123.27 |
| EPS Diluted Before Non-Recurring Items | N/A | -9.37 | -53.08 | -116.50 | -123.50 |
| EBITDA(a) | $-118,064 | $-90,127 | $-80,984 | $-56,632 | $-81,256 |